Sun Builds On Psoriasis Data But Can It Hold In Crowded Space?

 
• By Anju Ghangurde
Marathon runners
Sun Pharma's tildrakizumab faces a crowded competitive space • Source: Shutterstock

More from Clinical Trials

More from R&D